Analysis of a membrane‐enriched proteome from postmortem human brain tissue in Alzheimer's disease

Abstract

Purpose The present study is a discovery mode proteomics analysis of the membrane enriched fraction of post-mortem brain tissue from Alzheimer’s disease (AD) and control cases. This study aims to validate a method to identify new proteins that could be involved in the pathogenesis of AD and potentially serve as disease biomarkers. Experimental Design Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used to analyze the membrane enriched fraction of human post-mortem brain tissue from five AD and five control cases of similar age. Biochemical validation of specific targets was performed by immunoblotting. Results 1709 proteins were identified from the membrane enriched fraction of frontal cortex. Label free quantification by spectral counting and G-test analysis identified 13 proteins that were significantly changed in disease. In addition to Tau (MAPT), two additional proteins found to be enriched in AD, Ubiquitin carboxy-terminal hydrolase 1 (UCHL1), and syntaxin binding protein 1 (Munc-18), were validated through immunoblotting. Discussion and clinical relevance Proteomic analysis of the membrane enriched fraction of post-mortem brain tissue identifies proteins biochemically altered in AD. Further analysis of this sub-proteome may help elucidate mechanisms behind AD pathogenesis and provide new sources of biomarkers.

Brain quantitative proteomic responses reveal new insight of benzotriazole neurotoxicity in female Chinese rare minnow (Gobiocypris rarus)

“…In a previous study, CKBB and respiratory chain complexes activities were both observed to be altered by monoamine-based antidepressants in rat brain (Réus et al, 2012). Moreover, overexpression of CKBB has been demonstrated to be associated with AD (Donovan et al, 2012). Our proteomic data and the results of previous studies suggest that BT may disturb energy homeostasis in the CNS of fish, potentially leading to neurodegeneration; however this hypothesis must be tested in additional experiments.…”

Two Novel Tau Antibodies Targeting the 396/404 Region Are Primarily Taken Up by Neurons and Reduce Tau Protein Pathology

“…There is an increase in endocytic activities in AD brain (45), which could partially explain the uptake of mAbs by pathological neurons. Alternatively, it has been reported that AD neurons have a significantly higher amount of membrane-associated Tau protein (46). Membrane-associated pre-fibrillary Tau oligomers have been found to disrupt cell membrane integrity (47), which may allow the entry of Tau antibodies.…”

Interaction between misfolded PrP and the ubiquitin-proteasome system in prion-mediated neurodegeneration

“…A proteomic analysis reported that ubiquitin carboxyl-terminal hydrolase isozyme L1 (UCH-L1) found to be enriched in AD [50]. Amici et al [51] reported an increase of proteasome functionality in prion-associated disease and a higher incidence of protein oxidation in both aged and scrapie-infected subjects.…”